Israel’s Betalin Therapeutics (see here previously) is to receive capital from the European Innovation Council (EIC) fund. The funding will advance human trials of its biological pancreas that can produce insulin in the body independently, thus making injections unnecessary.

https://www.calcalistech.com/ctech/articles/0,7340,L-3912996,00.html